Varaporn Suphapimol
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting RORγ to Boost Regulatory T cells and Ameliorate Diabetic Retinopathy in Mice.
Journal: The American journal of pathology
Published: June 25, 2025
Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3+ Tregs and CD8+ T cells.
Journal: Diabetologia
Published: November 14, 2024
Alpha-1 antitrypsin reduces inflammation and vasculopathy in mice with oxygen-induced retinopathy.
Journal: Journal of inflammation (London, England)
Published: August 12, 2024
Early Depletion of Neutrophils Reduces Retinal Inflammation and Neovascularization in Mice with Oxygen-Induced Retinopathy.
Journal: International journal of molecular sciences
Published: September 08, 2023
Four-week inhibition of the renin-angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks.
Journal: Cardiovascular research
Published: August 04, 2023
Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy.
Journal: International journal of molecular sciences
Published: November 29, 2022
Angiotensin II and aldosterone in retinal vasculopathy and inflammation.
Journal: Experimental eye research
Published: June 11, 2019
Angiotensin II and aldosterone activate retinal microglia.
Journal: Experimental eye research
Published: June 06, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026